These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8385835)

  • 1. Histologic characterization of hepatic carcinogenesis in transgenic mice expressing SV40 T-antigens.
    Cullen JM; Sandgren EP; Brinster RL; Maronpot RR
    Vet Pathol; 1993 Mar; 30(2):111-8. PubMed ID: 8385835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
    Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
    Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SV40 large T antigen directed by regulatory elements of the human alpha-1-antitrypsin gene. A transgenic mouse system that exhibits stages in liver carcinogenesis.
    Butel JS; Sepulveda AR; Finegold MJ; Woo SL
    Intervirology; 1990; 31(2-4):85-100. PubMed ID: 2142679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP 3-month toxicity studies of estragole (CAS No. 140-67-0) administered by gavage to F344/N rats and B6C3F1 mice.
    Bristol DW
    Toxic Rep Ser; 2011 Jan; (82):1-111. PubMed ID: 21445103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunohistochemical profile of the so-called bile duct adenoma: clues to pathogenesis.
    Hughes NR; Goodman ZD; Bhathal PS
    Am J Surg Pathol; 2010 Sep; 34(9):1312-8. PubMed ID: 20679879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogene-induced liver neoplasia in transgenic mice.
    Sandgren EP; Quaife CJ; Pinkert CA; Palmiter RD; Brinster RL
    Oncogene; 1989 Jun; 4(6):715-24. PubMed ID: 2543942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicology and Carcinogenesis Studies of Furan (CAS No. 110-00-9) in F344 Rats and B6C3F1 Mice(Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Jan; 402():1-286. PubMed ID: 12621516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered differentiation of hepatocytes in a transgenic mouse model of hepatocarcinogenesis.
    Enomoto A; Sandgren EP; Maronpot RR
    Toxicol Pathol; 1998; 26(4):570-8. PubMed ID: 9715517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocarcinogenesis in transgenic mice carrying albumin-promoted SV40 T antigen gene.
    Hino O; Kitagawa T; Nomura K; Ohtake K; Cui L; Furuta Y; Aizawa S
    Jpn J Cancer Res; 1991 Nov; 82(11):1226-33. PubMed ID: 1684356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of transforming growth factor-alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice.
    Webber EM; Wu JC; Wang L; Merlino G; Fausto N
    Am J Pathol; 1994 Aug; 145(2):398-408. PubMed ID: 8053497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene.
    Sepulveda AR; Finegold MJ; Smith B; Slagle BL; DeMayo JL; Shen RF; Woo SL; Butel JS
    Cancer Res; 1989 Nov; 49(21):6108-17. PubMed ID: 2551499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutations are not selected for in simian virus 40 T-antigen-induced tumors from transgenic mice.
    Moore M; Teresky AK; Levine AJ; Seiberg M
    J Virol; 1992 Feb; 66(2):641-9. PubMed ID: 1370552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
    Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
    Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP technical report on the toxicology and carcinogenesis studies of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 May; (529):4-168. PubMed ID: 16835634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Apr; 450():1-321. PubMed ID: 12594525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multistep hepatocarcinogenesis in transgenic mice harboring SV40 T-antigen gene.
    Kitagawa T; Hino O; Lee GH; Li H; Liu J; Nomura K; Ohtake K; Furuta Y; Aizawa S
    Princess Takamatsu Symp; 1991; 22():349-60. PubMed ID: 1668891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic neoplasia in two polar bears.
    Miller RE; Boever WJ; Thornburg LP; Curtis-Velasco M
    J Am Vet Med Assoc; 1985 Dec; 187(11):1256-8. PubMed ID: 3001007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.